Appendix II — O — Decisions Cited — O
Ninth Edition, Revision 01.2024
[ Editor Note: Opinions of the Patent Trial and Appeal Board or its predecessor organizations (Board) made available to the public after the Board first published Standard Operating Procedure 2 in 1994 (addressing the publication of Board opinions and the designation of such opinions as precedential) that (1) expressly indicate that the opinion is binding precedent of the Board or (2) are identified as binding precedent on the Board’s Precedential opinion website ( www.uspto.gov/patents-application-process/appealing -patent-decisions/decisions-and-opinions/precedential ) are precedential and binding authority. Prior to 1994, a decision by the Board was considered binding on panels of the Board only if the opinion was authorized by the Board to be published. See Ex parte Holt, 19 USPQ2d 1211 (Bd.Pat. App. & Int. 1991).]
Editor Note: When possible, parallel citations to the United States Reports or Federal Reporter and the United States Patent Quarterly (USPQ) are provided and include pinpoint pages, if appropriate. However, decisions of the U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit published after July 11, 2022, no longer contain a pinpoint page for the USPQ citations.
Oakley, Inc. v. Sunglass Hut Int’l, 316 F.3d 1331, 65 USPQ2d 1321 (Fed. Cir. 2003) 2173.05(g)
Obiaya, Ex parte, 227 USPQ 58 (Bd. Pat. App. & Inter. 1985) 707.07(f) , 2145 , 2258
Ochiai, In re, 71 F.3d 1565, 37 USPQ2d 1127 (Fed. Cir. 1995) 2116.01 , 2144.08 , 2147 , 2158
Ockert, In re, 245 F.2d 467, 114 USPQ 330 (CCPA 1957) 804 , 804.01 , 804.02
Oda, In re, 443 F.2d 1200, 170 USPQ 268 (CCPA 1971) 2163 , 2163.07
OddzOn Products, Inc. v. Just Toys, Inc., 122 F.3d 1396, 43 USPQ2d 1641 (Fed. Cir. 1997) 2004 , 2146
Odetics Inc. v. Storage Tech. Corp., 185 F.3d 1259, 51 USPQ2d 1225 (Fed. Cir. 1999) 2183 , 2184
Oelrich, In re, 579 F.2d 86, 198 USPQ 210 (CCPA 1978) 716.01(c) , 2144.08 , 2145
Oelrich, In re, 666 F.2d 578, 212 USPQ 323 (CCPA 1981) 2112
Oetiker, Ex parte, 23 USPQ2d 1641 (Bd. Pat. App. & Inter. 1992) 2173.05(b)
Oetiker, In re, 977 F.2d 1443, 24 USPQ2d 1443 (Fed. Cir. 1992) 707.07(f) , 716.01(d) , 1504.01(a) , 1504.01(c) , 2107.02 , 2142 , 2144.08 , 2145 , 2164.07
O’Farrell, In re, 853 F.2d 894, 7 USPQ2d 1673 (Fed. Cir. 1988) 2143 , 2143.01 , 2143.02 , 2144.08 , 2145
Ogiue, In re, 517 F.2d 1382, 186 USPQ 227 (CCPA 1975) 2304.04(b)
Ohshiro, Ex parte, 14 USPQ2d 1750 (Bd. Pat. App. & Inter. 1989) 2163.05
O.I. Corp. v. Tekmar Corp., 115 F.3d 1576, 42 USPQ2d 1777 (Fed. Cir. 1997) 2181
OIP Techs., Inc. v. Amazon.com, Inc., 788 F.3d 1359, 115 USPQ2d 1090 (Fed. Cir. 2015) 2106.04(a)(2) , 2106.05(d) , 2106.05(e) , 2106.05(g) , 2106.07(a) , 2106.07(b)
Oka v. Youssefyeh, 849 F.2d 581, 7 USPQ2d 1169 (Fed. Cir. 1988) 2138.04
Okajima v. Bourdeau, 261 F.3d 1350, 59 USPQ2d 1795 (Fed. Cir. 2001) 2141.03
Okuzawa, In re, 537 F.2d 545, 190 USPQ 464 (CCPA 1976) 2111.01
Olah, Ex parte, 131 USPQ 41 (Bd. App. 1960) 213.03 , 2133 , 2135.01 , 2139.02
Old Town Canoe Co. v. Confluence Holdings Corp., 448 F.3d 1309, 78 USPQ2d 1705 (Fed. Cir. 2006) 2111.01
Omeprazole Patent Litigation, In re, 483 F.3d 1364, 82 USPQ2d 1643 (Fed. Cir. 2007) 2112
Omeprazole Patent Litigation, In re, 536 F.3d 1361, 87 USPQ2d 1865 (Fed. Cir. 2008) 2143
Onda, In re, 229 USPQ 235 (Comm’r Pat. 1985) 2146.02 , 2285
Opinion of Hon. Edward Bates, 10 Op. Atty. Gen. 137 (1861) 602.08(b)
Oppenauer, In re, 143 F.2d 974, 62 USPQ 297 (CCPA 1944) 716.09
Orbital Technologies Corporation, In re, 603 Fed. App’x 924 (Fed. Cir. 2015) 2120
O’Reilly v. Morse, 56 U.S. (15 How.) 62 (1854) 2106.04(b) , 2106.05(f)
Orita, In re, 550 F.2d 1277, 193 USPQ 145 (CCPA 1977) 1412.01 , 1457
Ormco Corp. v. Align Technology, Inc., 463 F.3d 1299, 79 USPQ2d 1931 (Fed. Cir. 2006) 2145
Orthokinetics, Inc. v. Safety Travel Chairs, Inc., 806 F.2d 1565, 1 USPQ2d 1081 (Fed. Cir. 1986) 2173.02 , 2173.05(b)
Ortho-McNeil Pharm., Inc. v. Caraco Pharm. Labs., Ltd., 476 F.3d 1321, 81 USPQ2d 1427 (Fed. Cir. 2007) 2173.05(b)
Ortho-McNeil Pharmaceutical, Inc. v. Lupin Pharmaceuticals, Inc., 603 F.3d 1377, 95 USPQ2d 1246 (Fed. Cir. 2010) 2751
Ortho-McNeil Pharm., Inc. v. Mylan Labs, Inc., 520 F.3d 1358, 86 USPQ2d 1196 (Fed. Cir. 2008) 2143
Orthopedic Equip. Co., Inc. v. All Orthopedic Appliances, Inc., 707 F.2d 1376, 217 USPQ 1281 (Fed. Cir. 1983) 716.04
OSI Pharm., LLC v. Apotex Inc., 939 F.3d 1375, 2019 USPQ2d 379681 (Fed. Cir. 2019) 2143.02
Osmond, Ex parte, 191 USPQ 334 (Bd. App. 1973) 711.06(a) , 2136
Osmond, Ex parte, 191 USPQ 340 (Bd. App. 1976) 711.06(a)
Osram Sylvania Inc., v. American Induction Tech., Inc., 701 F.3d 698, 105 USPQ2d 1368 (Fed. Cir. 2012) 2131.02
Ott v. Goodpasture, 40 USPQ2d 1831 (D. N.Tex. 1996) 410
Otto, In re, 312 F.2d 937, 136 USPQ 458 (CCPA 1963) 2111.02 , 2115
Ovist, Ex parte, 152 USPQ 709 (Bd. App. 1963) 2126.02
Ovshinsky, Ex parte, 10 USPQ2d 1075 (Bd. Pat. App. & Inter. 1989) 715.07
Owens, In re, 710 F.3d 1362, 106 USPQ2d 1248 (Fed. Cir. 2013) 1503.02 , 1504.04
Cited authority
- 2173.05(g) Functional Limitations
- 707.07(f) Answer All Material Traversed
- 2145 Consideration of Applicant’s Rebuttal Arguments and Evidence
- 2258 Scope of Ex Parte Reexamination
- 2116.01 Novel, Nonobvious Starting Material or End Product
- 2144.08 Obviousness of Species When Prior Art Teaches Genus
- 2147 Biotechnology Process Applications; Pre-AIA 35 U.S.C. 103(b)
- 2158 AIA 35 U.S.C. 103
- 804 Definition of Double Patenting
- 804.01 Prohibition of Nonstatutory Double Patenting Rejections Under 35 U.S.C. 121
- 804.02 Avoiding a Double Patenting Rejection
- 2163 Guidelines for the Examination of Patent Applications Under the 35 U.S.C. 112(a) or Pre-AIA 35 U.S.C. 112, first paragraph, “Written Description” Requirement
- 2163.07 Amendments to Application Which Are Supported in the Original Description
- 2004 Aids to Compliance With Duty of Disclosure
- 2146 Pre-AIA 35 U.S.C. 103(c)
- 2183 Making a Prima Facie Case of Equivalence
- 2184 Determining Whether an Applicant Has Met the Burden of Proving Nonequivalence After a Prima Facie Case Is Made
- 716.01(c) Probative Value of Objective Evidence
- 2112 Requirements of Rejection Based on Inherency; Burden of Proof
- 2173.05(b) Relative Terminology
- 716.01(d) Weighing Objective Evidence
- Title Page Title Page
- 1504.01(c) Lack of Ornamentality
- 2107.02 Procedural Considerations Related to Rejections for Lack of Utility
- 2142 Legal Concept of Prima Facie Obviousness
- 2164.07 Relationship of Enablement Requirement to Utility Requirement of 35 U.S.C. 101
- 2143 Examples of Basic Requirements of a Prima Facie Case of Obviousness
- 2143.01 Suggestion or Motivation To Modify the References
- 2143.02 Reasonable Expectation of Success Is Required
- 2304.04(b) Requiring a Claim
- 2163.05 Changes to the Scope of Claims
- 2181 Identifying and Interpreting a 35 U.S.C. 112(f) or Pre-AIA 35 U.S.C. 112, Sixth Paragraph Limitation
- 2106.04(a)(1) Examples of Claims That Do Not Recite Abstract Ideas
- 2106.05(d) Well-Understood, Routine, Conventional Activity
- 2106.05(e) Other Meaningful Limitations
- 2106.05(g) Insignificant Extra-Solution Activity
- 2106.07(a) Formulating a Rejection For Lack of Subject Matter Eligibility
- 2106.07(b) Evaluating Applicant’s Response
- 2138.04 “Conception”
- 2141.03 Level of Ordinary Skill in the Art
- 2111.01 Plain Meaning
- 213.03 Time for Filing U.S. Nonprovisional Application
- 2133 Pre-AIA 35 U.S.C. 102(b)
- 2135.01 The Four Requirements of Pre-AIA 35 U.S.C. 102(d)
- 2139.02 Determining Whether To Apply Pre-AIA 35 U.S.C. 102(a), (b), or (e)
- 2146.02 Establishing Common Ownership or Joint Research Agreement Under Pre-AIA 35 U.S.C. 103(c)
- 2285 Copending Ex Parte Reexamination and Reissue Proceedings
- 602.08(b) Inventor Signature and Name
- 716.09 Sufficiency of Disclosure
- 2120 Rejection on Prior Art
- 2106.04(b) Laws of Nature, Natural Phenomena & Products of Nature
- 2106.05(f) Mere Instructions To Apply An Exception
- 1412.01 Reissue Claims Must Be for Same General Invention
- 1457 Design Reissue Applications and Patents
- 2173.02 Determining Whether Claim Language is Definite
- 2751 Eligibility Requirements
- 716.04 Long-Felt Need and Failure of Others
- 711.06(a) Citation and Use of Abstracts, Abbreviatures, and Defensive Publications as References
- 2136 Pre-AIA 35 U.S.C. 102(e)
- 2131.02 Genus-Species Situations
- 410 Representations to the U.S. Patent and Trademark Office
- 2111.02 Effect of Preamble
- 2115 Material or Article Worked Upon by Apparatus
- 2126.02 Scope of Reference’s Disclosure Which Can Be Used to Reject Claims When the Reference Is a “Patent” but Not a “Publication”
- 715.07 Facts and Documentary Evidence
- 1503.02 Drawing
- 1504.04 Considerations Under 35 U.S.C. 112